295 related articles for article (PubMed ID: 10722703)
1. Loss of N-glycolylneuraminic acid in human evolution. Implications for sialic acid recognition by siglecs.
Brinkman-Van der Linden EC; Sjoberg ER; Juneja LR; Crocker PR; Varki N; Varki A
J Biol Chem; 2000 Mar; 275(12):8633-40. PubMed ID: 10722703
[TBL] [Abstract][Full Text] [Related]
2. A uniquely human consequence of domain-specific functional adaptation in a sialic acid-binding receptor.
Sonnenburg JL; Altheide TK; Varki A
Glycobiology; 2004 Apr; 14(4):339-46. PubMed ID: 14693915
[TBL] [Abstract][Full Text] [Related]
3. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
Angata T; Varki A
J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860
[TBL] [Abstract][Full Text] [Related]
4. A second uniquely human mutation affecting sialic acid biology.
Angata T; Varki NM; Varki A
J Biol Chem; 2001 Oct; 276(43):40282-7. PubMed ID: 11546777
[TBL] [Abstract][Full Text] [Related]
5. A single N-linked glycosylation site is implicated in the regulation of ligand recognition by the I-type lectins CD22 and CD33.
Sgroi D; Nocks A; Stamenkovic I
J Biol Chem; 1996 Aug; 271(31):18803-9. PubMed ID: 8702538
[TBL] [Abstract][Full Text] [Related]
6. Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily.
Kelm S; Pelz A; Schauer R; Filbin MT; Tang S; de Bellard ME; Schnaar RL; Mahoney JA; Hartnell A; Bradfield P
Curr Biol; 1994 Nov; 4(11):965-72. PubMed ID: 7533044
[TBL] [Abstract][Full Text] [Related]
7. Siglecs, sialic acids and innate immunity.
Crocker PR; Varki A
Trends Immunol; 2001 Jun; 22(6):337-42. PubMed ID: 11377294
[TBL] [Abstract][Full Text] [Related]
8. Colloquium paper: uniquely human evolution of sialic acid genetics and biology.
Varki A
Proc Natl Acad Sci U S A; 2010 May; 107 Suppl 2(Suppl 2):8939-46. PubMed ID: 20445087
[TBL] [Abstract][Full Text] [Related]
9. Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters.
Angata T; Hingorani R; Varki NM; Varki A
J Biol Chem; 2001 Nov; 276(48):45128-36. PubMed ID: 11579105
[TBL] [Abstract][Full Text] [Related]
10. Possible Influences of Endogenous and Exogenous Ligands on the Evolution of Human Siglecs.
Angata T
Front Immunol; 2018; 9():2885. PubMed ID: 30564250
[TBL] [Abstract][Full Text] [Related]
11. Sialoside specificity of the siglec family assessed using novel multivalent probes: identification of potent inhibitors of myelin-associated glycoprotein.
Blixt O; Collins BE; van den Nieuwenhof IM; Crocker PR; Paulson JC
J Biol Chem; 2003 Aug; 278(33):31007-19. PubMed ID: 12773526
[TBL] [Abstract][Full Text] [Related]
12. Functional evaluation of activation-dependent alterations in the sialoglycan composition of T cells.
Naito-Matsui Y; Takada S; Kano Y; Iyoda T; Sugai M; Shimizu A; Inaba K; Nitschke L; Tsubata T; Oka S; Kozutsumi Y; Takematsu H
J Biol Chem; 2014 Jan; 289(3):1564-79. PubMed ID: 24297165
[TBL] [Abstract][Full Text] [Related]
13. OB-BP1/Siglec-6. a leptin- and sialic acid-binding protein of the immunoglobulin superfamily.
Patel N; Brinkman-Van der Linden EC; Altmann SW; Gish K; Balasubramanian S; Timans JC; Peterson D; Bell MP; Bazan JF; Varki A; Kastelein RA
J Biol Chem; 1999 Aug; 274(32):22729-38. PubMed ID: 10428856
[TBL] [Abstract][Full Text] [Related]
14. Modifications of cell surface sialic acids modulate cell adhesion mediated by sialoadhesin and CD22.
Kelm S; Schauer R; Manuguerra JC; Gross HJ; Crocker PR
Glycoconj J; 1994 Dec; 11(6):576-85. PubMed ID: 7696861
[TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells.
Li N; Zhang W; Wan T; Zhang J; Chen T; Yu Y; Wang J; Cao X
J Biol Chem; 2001 Jul; 276(30):28106-12. PubMed ID: 11358961
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of the asparagine-linked oligosaccharides on siglec-5, siglec-7 and siglec-8, expressed in a CHO cell line, and their contribution to ligand recognition.
Freeman S; Birrell HC; D'Alessio K; Erickson-Miller C; Kikly K; Camilleri P
Eur J Biochem; 2001 Mar; 268(5):1228-37. PubMed ID: 11231274
[TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of human Siglec-11. A recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia.
Angata T; Kerr SC; Greaves DR; Varki NM; Crocker PR; Varki A
J Biol Chem; 2002 Jul; 277(27):24466-74. PubMed ID: 11986327
[TBL] [Abstract][Full Text] [Related]
18. The amino-terminal immunoglobulin-like domain of sialoadhesin contains the sialic acid binding site. Comparison with CD22.
Nath D; van der Merwe PA; Kelm S; Bradfield P; Crocker PR
J Biol Chem; 1995 Nov; 270(44):26184-91. PubMed ID: 7592823
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization, tissue expression, and mapping of a novel Siglec-like gene (SLG2) with three splice variants.
Yousef GM; Ordon MH; Foussias G; Diamandis EP
Biochem Biophys Res Commun; 2001 Jun; 284(4):900-10. PubMed ID: 11409878
[TBL] [Abstract][Full Text] [Related]
20. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
